France· FR:63581266
ATURGYL 0,05 POUR CENT, solution pour pulvérisation nasale
A medicinal product containing chlorhydrate d'oxymétazoline, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'OXYMÉTAZOLINE
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009300845641 flacon(s) polyéthylène de 15 mlEUR 1.44
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'oxymétazoline in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States12 Hour Nasal Decongestant Extra MoisturizingWinCo Foods LLC
- SpainAFRIN AROMA MANZANILLA 0,5 MG/ML SOLUCION PARA PULVERIZACION NASALBayer Hispania S.L.
- PolandAcatar CareUS Pharmacia Sp. z o.o.
- SwedenNasin 0,25 mg/ml Nässpray, lösningPerrigo Sverige AB
- CanadaCLARITIN ALLERGY DECONGESTANTBAYER INC
- United KingdomAfrazine 0.05% nasal spraySchering-Plough Ltd
- NetherlandsAfrin 0,5 mg/ml neusspray, oplossingBayer B.V.
- CzechiaAFRINBAYER s.r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Wick Nasiben Baby Sanft, Wick Nasivin Aloe & Eukalyptus
- Belgium · Nesivine, Nesivine Baby Sine Conservans
- Bulgaria · Vicks Sinex Aloe And Eucalyptus, Африн
- Czechia · Afrin, Afrin S Mentolem
- Germany · Nasivin Erwachsene Und Schulkinder, Nasivin Für Erwachsene Und Schulkinder
- Estonia · Afrin, Afrin Menthol
- Spain · Antirrinum Adultos Nueva Fórmula, Cuvenax
- Finland · Vicks, Vicks Sinex
- United Kingdom (Northern Ireland) · Blocked Nose Relief, Boots Decongestant
- Greece · Ezixin, Ronal
- Croatia · Nazopass, Operil P Za Djecu
- Hungary · Afrin, Afrin Comfort Mentollal
- Ireland · Vicks Sinex Micromist
- Iceland · Nezeril
- Italy · Equimet, Froben Raffreddore
- Lithuania · Afrin, Afrin Menthol
- Luxembourg · Nesivine, Nesivine Baby Sine Conservans
- Latvia · Afrin, Sinex
- Malta · Utabon Adults, Utabon Pediatric
- Netherlands · Afrin, Afrin Met Glycerol
- Norway · Rhinox
- Poland · Acatar Care, Acatar Care Kids
- Portugal · Alerjon, Bisolspray Nebulicina Adulto
- Romania · Afrin, Afrin Mentol
- Sweden · Nasin, Nezebi
- Slovenia · Afrin, Nazopass
- Slovakia · Afrin, Afrin S Mentolom
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc72145c-ba14-4d77-a1cd-4be1db711780 GET /v1/drugs/fc72145c-ba14-4d77-a1cd-4be1db711780?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63581266",
"date_amm": "1996-12-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE D'OXYMÉTAZOLINE",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution pour pulvérisation",
"voies_administration": "nasale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'oxymétazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.